These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21821524)

  • 1. Clinically useful cardioprotection: ischemic preconditioning then and now.
    Vander Heide R
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):251-4. PubMed ID: 21821524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion.
    Garcia-Dorado D; Rodriguez-Sinovas A; Ruiz-Meana M; Inserte J; Agulló L; Cabestrero A
    Cardiovasc Res; 2006 May; 70(2):274-85. PubMed ID: 16635642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing infarct size in the setting of acute myocardial infarction.
    Downey JM; Cohen MV
    Prog Cardiovasc Dis; 2006; 48(5):363-71. PubMed ID: 16627050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote ischemia conditioning-an endogenous cardioprotective strategy from outside the heart.
    Xiong J; Liao X; Xue FS; Yuan YJ; Wang Q; Liu JH
    Chin Med J (Engl); 2011 Jul; 124(14):2209-15. PubMed ID: 21933628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.
    Hausenloy DJ; Tsang A; Yellon DM
    Trends Cardiovasc Med; 2005 Feb; 15(2):69-75. PubMed ID: 15885573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresolved issues in myocardial reperfusion injury.
    Buja LM; Weerasinghe P
    Cardiovasc Pathol; 2010; 19(1):29-35. PubMed ID: 19026571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A "second window of protection" occurs 24 h after ischemic preconditioning in the rat heart.
    Yamashita N; Hoshida S; Taniguchi N; Kuzuya T; Hori M
    J Mol Cell Cardiol; 1998 Jun; 30(6):1181-9. PubMed ID: 9689592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of comorbidities in cardioprotection.
    Sack MN; Murphy E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):267-72. PubMed ID: 21821527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remote ischemic preconditioning].
    Maslov LN; Kolar F; Krieg T
    Usp Fiziol Nauk; 2009; 40(4):64-78. PubMed ID: 19886189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and protection against ischemia-reperfusion injury: from experimental data to potential clinical applications.
    Minguet G; Brichant JF; Joris J
    Acta Anaesthesiol Belg; 2012; 63(1):23-34. PubMed ID: 22783707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
    Vinten-Johansen J; Shi W
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to use the paradigm of ischemic preconditioning to protect the heart?].
    Argaud L; Ovize M
    Med Sci (Paris); 2004 May; 20(5):521-5. PubMed ID: 15190469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on selected aspects of cardioprotection.
    Jennings RB
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):340-8. PubMed ID: 21821537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic preconditioning: emerging evidence, controversy, and translational trials.
    Sanada S; Kitakaze M
    Int J Cardiol; 2004 Nov; 97(2):263-76. PubMed ID: 15458694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection in reperfusion with postconditioning.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.